INV-400 series

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameINV-400 series
Drug Alias NameInvasc-400 seriessterol regulatory element-binding protein 2 inhibitors (InVasc)INV-404INV-405INV-403
ClassificationSmall molecules
Mechanisms of ActionSterol regulatory element-binding protein 2 inhibitors
TargetsSterol regulatory element-binding protein 2
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInvasc Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInvasc Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A